Clinical Research Directory
Browse clinical research sites, groups, and studies.
University of Iowa Interventional Psychiatry Service Patient Registry
Sponsor: Mark Niciu
Summary
The purpose of this study is to examine the effects of interventional/procedural therapies for treatment-resistant depression (TRD) and Obsessive-Compulsive Disorder (OCD). These treatments include electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), racemic ketamine infusion and intranasal esketamine insufflation. The investigators will obtain various indicators, or biomarkers, of a depressed individuals' state before, during, and/or after these treatments. Such biomarkers include neurobehavioral testing, neuroimaging, electroencephalography, cognitive testing, vocal recordings, epi/genetic testing, and autonomic nervous system measures (i.e. "fight-or-flight" response). The results obtained from this study may provide novel antidepressant treatment response biomarkers, with the future goal of targeting a given treatment to an individual patient ("personalized medicine").
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2020-11-02
Completion Date
2050-08
Last Updated
2026-03-03
Healthy Volunteers
No
Conditions
Interventions
Electroconvulsive Therapy (ECT)
ECT for the treatment of treatment-resistant depression OR Bipolar Disorder in an active major depressive episode
Transcranial Magnetic Stimulation (TMS)
TMS for the treatment of treatment-resistant depression in an active major depressive episode
Ketamine
Intravenous ketamine infusion for the treatment of treatment-resistant depression in an active major depressive episode
Esketamine
Intranasal esketamine insufflation for the treatment of treatment-resistant depression in an active major depressive episode
Deep Transcranial Magnetic Stimulation (dTMS)
TMS for the treatment of OCD
Locations (1)
University of Iowa Health Care
Iowa City, Iowa, United States